Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Cisplatin Ototoxicity With the Antioxidant Alpha-Lipoic Acid

NCT00477607 is registered in ClinicalTrials.gov with US Department of Veterans Affairs as lead sponsor.

NCT NCT00477607
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00477607 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Cisplatin Ototoxicity With the Antioxidant Alpha-Lipoic Acid
Lead sponsor
US Department of Veterans Affairs
Phase
Phase 2/3
Overall status
Completed
Start date
October 31, 2007
Completion date
June 30, 2011
Enrollment
39 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ototoxicity, unspecified adult solid tumor